company

SIRIS BIOFOTONTERAPI AS

2614 LILLEHAMMER

Return on Equity
181,25 %
Current Ratio
0,59
Debt-to-Equity Ratio
−0
Key figures (NOK)2022
Revenue431 000
Net Income−87 000
Total Assets81 000
Total Equity−48 000
Income (NOK)2022
Revenue431 000
Expenditure518 000
Operating Profit−87 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax−87 000
Tax0
Net Income−87 000
Balance (NOK)2022
Total Fixed Assets6 000
Total Current Assets76 000
Total Assets81 000
Total Retained Equity−78 000
Total Equity−48 000
Total Long-Term Debt0
Total Current Debt129 000
Total Equity and Debt81 000
Cash flow (NOK)2022
Sales Income332 000
Other Income99 000
Revenue431 000
Cost of Goods Sold39 000
Salary Costs328 000
Depreciation6 000
Impairment0
Expenditure518 000
Operating Profit−87 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income−87 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures6 000
Total Tangible Assets6 000
Total Fiancial Fixed Assets0
Total Fixed Assets6 000
Stock0
Total Investments0
Cash, Bank75 000
Total Current Assets76 000
Total Assets81 000
Total Equity−48 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors2 000
Unpaid Taxes19 000
Dividends0
Other Current Debt102 000
Total Current Debt129 000
Total Equity and Debt81 000
Financial indicators2022
Return on Equity181,25 %
Debt-to-Equity Ratio−0
Operating Profit Margin−20,19 %
Current Ratio0,59
Quick Ratio0,59
Equity Ratio−0,59
Gross Profit Margin90,95 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English